ONO Pharmaceutical Co Financial Overview
ONO Pharmaceutical Co's market cap is currently ¥1.03T. The company's EPS TTM is ¥47.71; its P/E ratio is 21.33; and it has a dividend yield of 3.63%. ONO Pharmaceutical Co is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is ¥42.43. See an overview of income statement, balance sheet, and cash flow financials.
